Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × capmatinib × 90 days × Clear all

Phase

Status

Active not recruiting 3 Recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Specimen Handling 297 pembrolizumab 261 Magnetic Resonance Spectroscopy 244 Carboplatin 170 Biopsy 159 Cyclophosphamide 144 Cisplatin 140 Paclitaxel 117 Radiotherapy 110 Gemcitabine 105 Bevacizumab 105 Nivolumab 97 venetoclax 95 Dexamethasone 89 fludarabine 86 Fluorouracil 73 Rituximab 72 Oxaliplatin 70 Docetaxel 69 Capecitabine 68 Pemetrexed 67 Drug Therapy 67 Standard of Care 63 Radiosurgery 61 durvalumab 59 atezolizumab 58 Radiation 58 Injections 58 X-Rays 57 Leucovorin 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡